世界の脂質注射薬市場予測（～2028年）：イントラリピッド、リポシンIII、スモフリピッド、クリノリピッド、その他

• 英文タイトル：Global Lipid Injectable Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8879 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

脂質注射薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の脂質注射薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 脂質注射薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・イントラリピッド、リポシンIII、スモフリピッド、クリノリピッド、その他 用途別セグメントは次のように区分されます。 ・痛み軽減、毒性軽減、標的化ドラッグデリバリー、その他 世界の脂質注射薬市場の主要な市場プレーヤーは以下のとおりです。 ・Fresenius Kabi、Abbott Laboratories、Pfizer、B. Braun Melsungen AG、Heron Therapeutics Inc.、The Medicines Company (Novartis)、Baxter International Inc. 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、脂質注射薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な脂質注射薬メーカーの企業概要、2019年～2022年までの脂質注射薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な脂質注射薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別脂質注射薬の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの脂質注射薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での脂質注射薬市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および脂質注射薬の産業チェーンを掲載しています。 ・第13、14、15章では、脂質注射薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Fresenius Kabi、Abbott Laboratories、Pfizer、B. Braun Melsungen AG、Heron Therapeutics Inc.、The Medicines Company (Novartis)、Baxter International Inc. ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：イントラリピッド、リポシンIII、スモフリピッド、クリノリピッド、その他 ・用途別分析2017年-2028年：痛み軽減、毒性軽減、標的化ドラッグデリバリー、その他 ・脂質注射薬の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・脂質注射薬のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・脂質注射薬のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・脂質注射薬の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・脂質注射薬の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Lipid Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Lipid Injectable Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pain Reduction accounting for % of the Lipid Injectable Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Intralipid segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Lipid Injectable Drugs include Fresenius Kabi, Abbott Laboratories, Pfizer, B. Braun Melsungen AG, and Heron Therapeutics Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Lipid Injectable Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intralipid
Liposyn III
Smoflipid
Clinolipid
Others
Market segment by Application can be divided into
Pain Reduction
Toxicity Reduction
Targeted Drug Delivery
Others
The key market players for global Lipid Injectable Drugs market are listed below:
Fresenius Kabi
Abbott Laboratories
Pfizer
B. Braun Melsungen AG
Heron Therapeutics Inc.
The Medicines Company (Novartis)
Baxter International Inc.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lipid Injectable Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Lipid Injectable Drugs, with price, sales, revenue and global market share of Lipid Injectable Drugs from 2019 to 2022.
Chapter 3, the Lipid Injectable Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lipid Injectable Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Lipid Injectable Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lipid Injectable Drugs.
Chapter 13, 14, and 15, to describe Lipid Injectable Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Lipid Injectable Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Lipid Injectable Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Intralipid
1.2.3 Liposyn III
1.2.4 Smoflipid
1.2.5 Clinolipid
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Lipid Injectable Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pain Reduction
1.3.3 Toxicity Reduction
1.3.4 Targeted Drug Delivery
1.3.5 Others
1.4 Global Lipid Injectable Drugs Market Size & Forecast
1.4.1 Global Lipid Injectable Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Lipid Injectable Drugs Sales in Volume (2017-2028)
1.4.3 Global Lipid Injectable Drugs Price (2017-2028)
1.5 Global Lipid Injectable Drugs Production Capacity Analysis
1.5.1 Global Lipid Injectable Drugs Total Production Capacity (2017-2028)
1.5.2 Global Lipid Injectable Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Lipid Injectable Drugs Market Drivers
1.6.2 Lipid Injectable Drugs Market Restraints
1.6.3 Lipid Injectable Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Fresenius Kabi
2.1.1 Fresenius Kabi Details
2.1.2 Fresenius Kabi Major Business
2.1.3 Fresenius Kabi Lipid Injectable Drugs Product and Services
2.1.4 Fresenius Kabi Lipid Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Lipid Injectable Drugs Product and Services
2.2.4 Abbott Laboratories Lipid Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Lipid Injectable Drugs Product and Services
2.3.4 Pfizer Lipid Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 B. Braun Melsungen AG
2.4.1 B. Braun Melsungen AG Details
2.4.2 B. Braun Melsungen AG Major Business
2.4.3 B. Braun Melsungen AG Lipid Injectable Drugs Product and Services
2.4.4 B. Braun Melsungen AG Lipid Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Heron Therapeutics Inc.
2.5.1 Heron Therapeutics Inc. Details
2.5.2 Heron Therapeutics Inc. Major Business
2.5.3 Heron Therapeutics Inc. Lipid Injectable Drugs Product and Services
2.5.4 Heron Therapeutics Inc. Lipid Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 The Medicines Company (Novartis)
2.6.1 The Medicines Company (Novartis) Details
2.6.2 The Medicines Company (Novartis) Major Business
2.6.3 The Medicines Company (Novartis) Lipid Injectable Drugs Product and Services
2.6.4 The Medicines Company (Novartis) Lipid Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Baxter International Inc.
2.7.1 Baxter International Inc. Details
2.7.2 Baxter International Inc. Major Business
2.7.3 Baxter International Inc. Lipid Injectable Drugs Product and Services
2.7.4 Baxter International Inc. Lipid Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Lipid Injectable Drugs Breakdown Data by Manufacturer
3.1 Global Lipid Injectable Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Lipid Injectable Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Lipid Injectable Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Lipid Injectable Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Lipid Injectable Drugs Manufacturer Market Share in 2021
3.5 Global Lipid Injectable Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Lipid Injectable Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Lipid Injectable Drugs Market Size by Region
4.1.1 Global Lipid Injectable Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Lipid Injectable Drugs Revenue by Region (2017-2028)
4.2 North America Lipid Injectable Drugs Revenue (2017-2028)
4.3 Europe Lipid Injectable Drugs Revenue (2017-2028)
4.4 Asia-Pacific Lipid Injectable Drugs Revenue (2017-2028)
4.5 South America Lipid Injectable Drugs Revenue (2017-2028)
4.6 Middle East and Africa Lipid Injectable Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Lipid Injectable Drugs Sales in Volume by Type (2017-2028)
5.2 Global Lipid Injectable Drugs Revenue by Type (2017-2028)
5.3 Global Lipid Injectable Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Lipid Injectable Drugs Sales in Volume by Application (2017-2028)
6.2 Global Lipid Injectable Drugs Revenue by Application (2017-2028)
6.3 Global Lipid Injectable Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Lipid Injectable Drugs Sales by Type (2017-2028)
7.2 North America Lipid Injectable Drugs Sales by Application (2017-2028)
7.3 North America Lipid Injectable Drugs Market Size by Country
7.3.1 North America Lipid Injectable Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Lipid Injectable Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Lipid Injectable Drugs Sales by Type (2017-2028)
8.2 Europe Lipid Injectable Drugs Sales by Application (2017-2028)
8.3 Europe Lipid Injectable Drugs Market Size by Country
8.3.1 Europe Lipid Injectable Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Lipid Injectable Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Lipid Injectable Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Lipid Injectable Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Lipid Injectable Drugs Market Size by Region
9.3.1 Asia-Pacific Lipid Injectable Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Lipid Injectable Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Lipid Injectable Drugs Sales by Type (2017-2028)
10.2 South America Lipid Injectable Drugs Sales by Application (2017-2028)
10.3 South America Lipid Injectable Drugs Market Size by Country
10.3.1 South America Lipid Injectable Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Lipid Injectable Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Lipid Injectable Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Lipid Injectable Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Lipid Injectable Drugs Market Size by Country
11.3.1 Middle East & Africa Lipid Injectable Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Lipid Injectable Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Lipid Injectable Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Lipid Injectable Drugs
12.3 Lipid Injectable Drugs Production Process
12.4 Lipid Injectable Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Lipid Injectable Drugs Typical Distributors
13.3 Lipid Injectable Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---